AI & Machine LearningEvolutionary Algorithms in Digital Healthcare
We specialise in developing technologies for the diagnosis and monitoring of Parkinson’s, Alzheimer’s and other neurodegenerative conditions. Our clinically-validated medical devices have been used in medical centres and clinical trials worldwide.
Introducing ClearSky MD
Who we are
ClearSky Medical Diagnostics began as a collaboration with specialists from Leeds General Infirmary, Heriot-Watt University and the University of York who provided clinical expertise and machine learning knowledge.
We’re led by Professor Stephen Smith, who has been hailed a ‘national lifesaver’ in recognition of his research into the diagnosis and treatment of Parkinson’s.
Monitoring side-effects of medication for Parkinson’s. LID-Monitor offers a safe, simple and unobtrusive way of monitoring dyskinesia in the home.
Differentiating between neurodegenerative conditions. Data gloves with positioning sensors are worn to monitor how people perform simple test-grasp tasks.
Confirming diagnosis of Parkinson’s disease. PD-Monitor assists specialists by measuring symptoms of Parkinson’s while patients undertake routine clinical tasks.
Objectively assessing visuo-spatial ability. Patients draw on a digitising tablet and their hesitations and differences in movements are measured and analysed by the evolutionary algorithms.
ClearSky MD is a UK Life Sciences Innovator 2023
ClearSky Medical Diagnostics has been selected as a UK Life Sciences Innovator 2023 by the UK’s Department for International Trade (DIT).
ClearSky presents at MEDICA 2022 in Germany
ClearSky attended MEDICA 2022 in Germany as part of the UK Healthcare Pavilion, supported by the Department for International Trade.
ClearSky heads to 2022 MDS International Congress in Madrid
The ClearSky Medical Diagnostics team is attending the International Parkinson and Movement Disorder Society (MDS) Congress in Madrid.
We offer a range of consultancy services.
We have a number of clinical studies underway.
Get in touch